In vivo generated hematopoietic stem cells from genome edited induced pluripotent stem cells are functional in platelet-targeted gene therapy of murine hemophilia A

利用基因组编辑诱导多能干细胞在体内生成的造血干细胞，可用于靶向血小板的基因治疗小鼠血友病A。